SHIELDING CHILDREN

Stage of development

PFIZER-BIONTECH & MODERNA (US)

Administered to 12-plus age group; trials on for children aged 5 to 11; not available in India yet

ZYDUS CADILA (INDIA)

Approved for 12-plus; plans to start trials on 5-plus

BHARAT BIOTECH (INDIA)

Trials done on 12-plus; trials on for 2-plus

SINOVAC & SINOPHARM (CHINA)

Approved for ages 3-17; not available in India

SPUTNIK V (RUSSIA)

Nasal vaccine trials on children ongoing in Russia. Expected to be over by Sept-oct

COVOVAX (NOVAVAX CANDIDATE) (US)

Trials to start on children 2 years and above in India